INTERMEDIATE RISK PROSTATE CANCER
Clinical trials for INTERMEDIATE RISK PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new INTERMEDIATE RISK PROSTATE CANCER trials appear
Sign up with your email to follow new studies for INTERMEDIATE RISK PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shorter, stronger radiation for prostate cancer: a new hope?
Disease control OngoingThis pilot study tests two ultra-high-dose radiation schedules in 31 men with intermediate-risk prostate cancer. One group gets five high-dose sessions over a week; the other gets a single massive dose. The goal is to see if these shorter treatments are safe and can control the c…
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: PHASE1 • Sponsor: Albert Einstein College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Double punch for prostate cancer: electric pulses plus radiation
Disease control OngoingThis study tests a new approach for men with intermediate-risk prostate cancer. First, doctors use electric pulses (IRE) to destroy tumor cells, followed by precise radiation (MRgRT). The goal is to see if this combination is safe and can keep cancer away for at least a year. Abo…
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Radioactive seeds take aim at prostate cancer without extra hormones
Disease control OngoingThis study tests whether a one-time procedure called brachytherapy, where tiny radioactive seeds are placed directly into the prostate, can control intermediate risk prostate cancer without needing additional treatments. Three hundred men with specific tumor features (Gleason sco…
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Prostate cancer radiation gets a boost: MR-Guided trial aims to halve recurrence
Disease control OngoingThis phase II study tests whether giving an extra-high radiation dose directly to the main prostate tumor, while treating the rest of the prostate with standard SBRT, can reduce the chance of cancer coming back. About 91 men with intermediate-risk prostate cancer will receive fiv…
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New combo aims to control prostate cancer without sacrificing erections
Disease control OngoingThis study compares a newer hormone therapy (darolutamide) plus radiation against standard hormone therapy plus radiation for men with intermediate-risk prostate cancer. The goal is to see if the new approach controls the cancer just as well while helping men keep better erectile…
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Shorter radiation blasts prostate tumors in early trial
Disease control OngoingThis early-phase study tests a new, ultra-short course of radiation therapy for men with intermediate-risk prostate cancer. The treatment uses MRI guidance to precisely target the prostate and the main tumor inside it. The goal is to see if this approach is safe and practical, wi…
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New radiation cocktail aims to cut prostate cancer treatment time
Disease control OngoingThis phase 1 trial tests a combination of two radiation techniques for men with intermediate risk prostate cancer. First, a high dose of radiation is placed inside the prostate for 10-20 minutes (brachytherapy), followed by three weeks of highly targeted external radiation (SBRT)…
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 26, 2026 16:10 UTC
-
Double scan strategy could sharpen prostate cancer staging
Diagnosis OngoingThis study looks at whether combining PSMA-PET/CT and MRI scans can more accurately determine the extent of prostate cancer in men with intermediate- or high-risk disease. Researchers will compare scan results with tissue samples from 600 men who had their prostate removed. The g…
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
New gel shields bowel during prostate radiation – could cut side effects
Symptom relief OngoingThis trial tests a biodegradable gel called SpaceOAR Vue that is injected between the prostate and rectum before radiation therapy. The gel temporarily pushes the rectum away to reduce radiation damage. About 500 men with intermediate-risk prostate cancer will be randomly assigne…
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Can a Pre-Surgery diet change help prostate cancer patients?
Knowledge-focused OngoingThis study looks at whether men with intermediate-risk prostate cancer can follow a Mediterranean diet before their surgery to remove the prostate. The goal is to see if this diet is practical and well-tolerated. Twelve participants will eat specially prepared meals and then unde…
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Can your breath predict radiation side effects? new study investigates
Knowledge-focused OngoingThis study looks at new ways to predict how prostate cancer and nearby healthy tissues react to a precise type of radiation therapy called SBRT. Researchers will analyze breath samples, blood DNA, and CT scans from 60 men with low- or intermediate-risk prostate cancer. The goal i…
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Sponsor: NHS Lothian • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC